These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34352165)

  • 1. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Viguera AC; Freeman MP; Góez-Mogollón L; Sosinsky AZ; McElheny SA; Church TR; Young AV; Caplin PS; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychiatry; 2021 Aug; 82(4):. PubMed ID: 34352165
    [No Abstract]   [Full Text] [Related]  

  • 2. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Cohen LS; Viguera AC; McInerney KA; Freeman MP; Sosinsky AZ; Moustafa D; Marfurt SP; Kwiatkowski MA; Murphy SK; Farrell AM; Chitayat D; Hernández-Díaz S
    Am J Psychiatry; 2016 Mar; 173(3):263-70. PubMed ID: 26441156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of the National Pregnancy Registry for Atypical Antipsychotics.
    Cohen LS; Viguera AC; McInerney KA; Kwiatkowski MA; Murphy SK; Lemon EL; Hernández-Díaz S
    J Clin Psychiatry; 2015 Jul; 76(7):986-9. PubMed ID: 25939066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Freeman MP; Viguera AC; Góez-Mogollón L; Young AV; Caplin PS; McElheny SA; Church TR; Chitayat D; Hernández-Díaz S; Cohen LS
    Arch Womens Ment Health; 2021 Aug; 24(4):659-667. PubMed ID: 33710399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine.
    Cohen LS; Góez-Mogollón L; Sosinsky AZ; Savella GM; Viguera AC; Chitayat D; Hernández-Díaz S; Freeman MP
    Am J Psychiatry; 2018 Dec; 175(12):1225-1231. PubMed ID: 30111186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of atypical antipsychotics in pregnancy and maternal gestational diabetes.
    Panchaud A; Hernandez-Diaz S; Freeman MP; Viguera AC; MacDonald SC; Sosinsky AZ; Cohen LS
    J Psychiatr Res; 2017 Dec; 95():84-90. PubMed ID: 28810177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; Freeman MP; Kobylski LA; Rossa ET; Gaccione P; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):106-112. PubMed ID: 36825887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications.
    Cohen LS; Church TR; Freeman MP; Gaccione P; Caplin PS; Kobylski LA; Arakelian M; Rossa ET; Chitayat D; Hernández-Díaz S; Viguera AC
    J Womens Health (Larchmt); 2023 Apr; 32(4):452-462. PubMed ID: 36716275
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS
    J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National Pregnancy Registry for Psychiatric Medications.
    Freeman MP; Szpunar MJ; Kobylski LA; Harmon H; Viguera AC; Cohen LS
    Arch Womens Ment Health; 2022 Oct; 25(5):923-928. PubMed ID: 35840767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis.
    Terrana N; Koren G; Pivovarov J; Etwel F; Nulman I
    J Clin Psychopharmacol; 2015 Oct; 35(5):559-65. PubMed ID: 26274044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US.
    Huybrechts KF; Straub L; Karlsson P; Pazzagli L; Furu K; Gissler M; Hernandez-Diaz S; Nørgaard M; Zoega H; Bateman BT; Cesta CE; Cohen JM; Leinonen MK; Reutfors J; Selmer RM; Suarez EA; Ulrichsen SP; Kieler H
    JAMA Psychiatry; 2023 Feb; 80(2):156-166. PubMed ID: 36477338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
    Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
    JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.
    McKenna K; Koren G; Tetelbaum M; Wilton L; Shakir S; Diav-Citrin O; Levinson A; Zipursky RB; Einarson A
    J Clin Psychiatry; 2005 Apr; 66(4):444-9; quiz 546. PubMed ID: 15816786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997-2011.
    Anderson KN; Ailes EC; Lind JN; Broussard CS; Bitsko RH; Friedman JM; Bobo WV; Reefhuis J; Tinker SC;
    Schizophr Res; 2020 Jan; 215():81-88. PubMed ID: 31761471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of major malformations in infants after first-trimester exposure to benzodiazepines: Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
    Szpunar MJ; Freeman MP; Kobylski LA; Caplin PS; Gaccione P; Viguera AC; Chitayat D; Hernández-Díaz S; Cohen LS
    Depress Anxiety; 2022 Dec; 39(12):751-759. PubMed ID: 35909254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy.
    Freeman MP; Sosinsky AZ; Goez-Mogollon L; Savella GM; Moustafa D; Viguera AC; Cohen LS
    Psychosomatics; 2018; 59(2):125-134. PubMed ID: 29078988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy Outcomes With Exposure to Second-Generation Antipsychotics During the First Trimester.
    Yakuwa N; Takahashi K; Anzai T; Ito N; Goto M; Koinuma S; Uno C; Suzuki T; Watanabe O; Yamatani A; Murashima A
    J Clin Psychiatry; 2022 Jun; 83(4):. PubMed ID: 35687862
    [No Abstract]   [Full Text] [Related]  

  • 19. Supplement use by women during pregnancy: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Freeman MP; Sosinsky AZ; Moustafa D; Viguera AC; Cohen LS
    Arch Womens Ment Health; 2016 Jun; 19(3):437-41. PubMed ID: 26472040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal use of antipsychotics in early pregnancy and delivery outcome.
    Reis M; Källén B
    J Clin Psychopharmacol; 2008 Jun; 28(3):279-88. PubMed ID: 18480684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.